Literature DB >> 17652033

Activation of Orexin B receptors in the pontine Kölliker-Fuse nucleus modulates pre-inspiratory hypoglossal motor activity in rat.

Mathias Dutschmann1, Miriam Kron, Michael Mörschel, Christian Gestreau.   

Abstract

Orexins (splice variants A and B) are hypothalamic neuropeptides that have essential functions in control of arousal and nutrition. Lack of Orexins is strongly associated with narcolepsy and sleep disordered breathing. However, the role of Orexins and particularly that of Orexin-B (OXB), in respiratory centres controlling upper-airway patency are less defined. In the present study we performed microinjections of OXB into the pontine Kölliker-Fuse nucleus (KF) of the dorsolateral pons, since this nucleus is particularly involved in the pre-motor control of upper airway muscles. The OXB mediated effects on heart, phrenic (PNA) and hypoglossal (XII-A) nerve activities were analysed in an in situ perfused brainstem preparation. Injection of OXB into the KF evoked significant augmentation of the respiratory frequency. Importantly, OXB provoked particularly prolonged pre-inspiratory discharge of the XII nerve, while no cardiovascular response was observed after KF microinjections. In summary, OXB in the KF exerts an excitatory effect on XII pre-motoneurones. Since pre-inspiratory activity of the XII is important for the decrease in upper airway resistance during inspiration, we conclude that OXB release in the KF has strong implications in the state-dependent control of upper airway patency under physiological and pathophysiological conditions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17652033     DOI: 10.1016/j.resp.2007.06.004

Source DB:  PubMed          Journal:  Respir Physiol Neurobiol        ISSN: 1569-9048            Impact factor:   1.931


  28 in total

Review 1.  The Kölliker-Fuse nucleus: a review of animal studies and the implications for cranial nerve function in humans.

Authors:  Nanna Browaldh; Tara G Bautista; Mathias Dutschmann; Robert G Berkowitz
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12-19       Impact factor: 2.503

2.  Kölliker–Fuse neurons send collateral projections to multiple hypoxia-activated and nonactivated structures in rat brainstem and spinal cord.

Authors:  Gang Song; Hui Wang; Hui Xu; Chi-Sang Poon
Journal:  Brain Struct Funct       Date:  2012-01-28       Impact factor: 3.270

Review 3.  State-dependent central chemoreception: a role of orexin.

Authors:  Tomoyuki Kuwaki; Aihua Li; Eugene Nattie
Journal:  Respir Physiol Neurobiol       Date:  2010-02-17       Impact factor: 1.931

Review 4.  Pontine mechanisms of respiratory control.

Authors:  Mathias Dutschmann; Thomas E Dick
Journal:  Compr Physiol       Date:  2012-10       Impact factor: 9.090

Review 5.  The hypocretins/orexins: integrators of multiple physiological functions.

Authors:  Jingcheng Li; Zhian Hu; Luis de Lecea
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 6.  Central chemoreception in wakefulness and sleep: evidence for a distributed network and a role for orexin.

Authors:  Eugene Nattie; Aihua Li
Journal:  J Appl Physiol (1985)       Date:  2010-02-04

Review 7.  Orexin, stress, and anxiety/panic states.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; William A Truitt; Anantha Shekhar
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

Review 8.  Respiration and autonomic regulation and orexin.

Authors:  Eugene Nattie; Aihua Li
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

9.  Orexin A activates hypoglossal motoneurons and enhances genioglossus muscle activity in rats.

Authors:  G H Zhang; Z L Liu; B J Zhang; W Y Geng; N N Song; W Zhou; Y X Cao; S Q Li; Z L Huang; L L Shen
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

10.  Antagonism of orexin receptor-1 in the retrotrapezoid nucleus inhibits the ventilatory response to hypercapnia predominantly in wakefulness.

Authors:  Mirela Barros Dias; Aihua Li; Eugene E Nattie
Journal:  J Physiol       Date:  2009-03-09       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.